| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by continuing operating activities | 2,079 | 1,080 |
| Net cash used in operating activities | -23 | -70 |
| Net increase in cash | 2,056 | 1,010 |
| Cash and cash equivalents at beginning of period | 5,059 | - |
| Cash and cash equivalents at end of period | 7,115 | - |
TherapeuticsMD, Inc. (TXMD)
TherapeuticsMD, Inc. (TXMD)